Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C21H30N4O4.C4H6O6 |
| Molecular Weight | 552.5741 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@H]([C@@H](O)C(O)=O)C(O)=O.CCOC1=C(C=C(C(N)=C1)[N+]([O-])=O)C(=O)NC2CCN(CC3CCC=CC3)CC2
InChI
InChIKey=HVANMRCHFMTSEG-LREBCSMRSA-N
InChI=1S/C21H30N4O4.C4H6O6/c1-2-29-20-13-18(22)19(25(27)28)12-17(20)21(26)23-16-8-10-24(11-9-16)14-15-6-4-3-5-7-15;5-1(3(7)8)2(6)4(9)10/h3-4,12-13,15-16H,2,5-11,14,22H2,1H3,(H,23,26);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1
| Molecular Formula | C4H6O6 |
| Molecular Weight | 150.0868 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | C21H30N4O4 |
| Molecular Weight | 402.4873 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Cinitapride is an agonist of 5-HT4 and 5-HT1 receptors and antagonist of 5-HT2 receptors. Cinitapride is marketed worldwide for the treatment of gastrointestinal disorders related to motility such as indigestion or functional or non-ulcer dyspepsia, gastroesophageal reflux diseases, delay in gastric emptying and vomiting.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Efficacy and tolerability of cinitapride in the treatment of functional dyspepsia and delayed gastric emptying]. | 2009-12 |
|
| [Prokinetic agents as a cause of granulomatous interstitial nephritis]. | 2007-12 |
|
| The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole. | 2007-07 |
|
| Effects of cinitapride on gastric ulceration and secretion in rats. | 1998-03 |
|
| Cinitapride protects against ethanol-induced gastric mucosal injury in rats: role of 5-hydroxytryptamine, prostaglandins and sulfhydryl compounds. | 1997-04 |
|
| [Metoclopramide versus cinitapride in the treatment of functional dyspepsia]. | 1993-07 |
|
| [Cinitapride in the treatment of gastroesophageal reflux. Comparative study with metoclopramide and placebo]. | 1992-01-01 |
|
| [Efficacy and tolerance of cinitapride on the disturbances of gastrointestinal transit]. | 1991-07-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:50:03 GMT 2025
by
admin
on
Mon Mar 31 22:50:03 GMT 2025
|
| Record UNII |
2Z90GEN540
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000090189
Created by
admin on Mon Mar 31 22:50:03 GMT 2025 , Edited by admin on Mon Mar 31 22:50:03 GMT 2025
|
PRIMARY | |||
|
SUB01312MIG
Created by
admin on Mon Mar 31 22:50:03 GMT 2025 , Edited by admin on Mon Mar 31 22:50:03 GMT 2025
|
PRIMARY | |||
|
1207859-16-2
Created by
admin on Mon Mar 31 22:50:03 GMT 2025 , Edited by admin on Mon Mar 31 22:50:03 GMT 2025
|
PRIMARY | |||
|
2Z90GEN540
Created by
admin on Mon Mar 31 22:50:03 GMT 2025 , Edited by admin on Mon Mar 31 22:50:03 GMT 2025
|
PRIMARY | |||
|
m3565
Created by
admin on Mon Mar 31 22:50:03 GMT 2025 , Edited by admin on Mon Mar 31 22:50:03 GMT 2025
|
PRIMARY | Merck Index | ||
|
DBSALT002860
Created by
admin on Mon Mar 31 22:50:03 GMT 2025 , Edited by admin on Mon Mar 31 22:50:03 GMT 2025
|
PRIMARY | |||
|
6917844
Created by
admin on Mon Mar 31 22:50:03 GMT 2025 , Edited by admin on Mon Mar 31 22:50:03 GMT 2025
|
PRIMARY | |||
|
96623-56-2
Created by
admin on Mon Mar 31 22:50:03 GMT 2025 , Edited by admin on Mon Mar 31 22:50:03 GMT 2025
|
NON-SPECIFIC STOICHIOMETRY |